The peer-review process is a fundamental component of the scientific quality and credibility of Digital Healthcare Innovation and Technologies (DHIT). Reviewers play a critical role in evaluating the rigor, originality, ethical compliance, and scientific contribution of manuscripts submitted to the journal. All reviewers are selected based on their expertise in medicine, biomedical engineering, health informatics, digital health technologies, and other relevant interdisciplinary fields.
Before accepting an invitation, reviewers are expected to carefully consider their responsibilities and adhere to the ethical principles outlined below.
1. Reviewer Selection and Responsibilities
Reviewers are chosen from among experts with demonstrated competence in the subject matter of the submitted manuscript. All invited reviewers are informed about:
The responsibilities and ethical expectations of reviewers
The confidentiality requirements of the double-masked review process
The evaluation criteria specific to DHIT
The timeline and structure of the review procedure
By accepting the review invitation, reviewers confirm that they possess the required expertise to evaluate the manuscript objectively, respect the confidentiality of the process, and are committed to completing the evaluation within the allotted time.
2. Deadlines and Workflow
Decision to Accept or Decline Review: Reviewers must respond within 7 days of receiving the invitation. Those who do not respond within this period are automatically assumed to have declined, and a new reviewer will be appointed.
Review completion time: Reviewers who accept the invitation must submit their evaluation within 60 days of the acceptance date.
Request for extension: Reviewers may request an extension of up to 10 days if additional time is needed.
Failure to submit a review: If no review or extension request is submitted within the timeline, the editorial office may assign a new reviewer.
3. Confidentiality and Ethical Principles
Reviewers must treat all manuscripts as strictly confidential documents.
Manuscripts, data, images, digital files, clinical information, and any supplementary material may not be shared, copied, stored, or used for personal research.
Communication with authors is strictly prohibited; all inquiries must be made through the editor via the DergiPark messaging system.
Reviewers must not evaluate a manuscript if they foresee any conflict of interest, including personal, financial, institutional, or collaborative relationships with the authors.
Any potential conflict must be immediately reported to the editorial board. COPE’s Conflict of Interest framework is followed for all such cases.
4. Evaluation Criteria
Reviewers are required to complete the DHIT review form, which includes both structured questions and space for detailed comments to the author. Reviewers must provide clear, evidence-based assessments and indicate whether revisions are needed.
In medical, clinical, and digital health manuscripts, reviewers must evaluate:
Title: Does it accurately reflect the study content?
Abstract: Is it clear, structured, and representative of the manuscript?
Scientific Quality: Are the methods, data, analyses, and conclusions sound?
Ethical Compliance:
Ethical committee approval (for clinical, human, or animal research)
Patient consent (when applicable)
Privacy, data protection, and confidentiality standards
Relevance and Novelty: Is the study original, impactful, and relevant to digital health or medical sciences?
Literature Review: Adequacy, currency, and relevance of references
Digital Components: In studies involving AI, machine learning, IoT, health informatics, decision-support systems, or telemedicine, are algorithms, datasets, and technologies clearly described?
Clarity and Organization: Language quality, structure, flow, and coherence
Tables/Figures: Accuracy, placement, ethical and technical suitability
Plagiarism or Ethical Concerns: Any signals of misconduct, inappropriate self-citations, or duplicated publication
Conflict of Interest Indications: Any undeclared biases or questionable relationships
Overall Contribution: Scientific, clinical, or technological impact
Reviewers may select from the following options: Yes, No, or Needs Revision for each evaluation item.
5. Reviewer Decisions
After completing the evaluation form, reviewers must provide a recommendation among the following:
Major Revision
Minor Revision
Reject
Accept (as is)
Reviewers must justify each recommendation with specific comments, particularly for items marked “No” or “Needs Revision.”
If a major Revision is recommended, reviewers may request to reassess the manuscript after the Revision. An additional 15 days will be granted for re-evaluation.
6. Number of Reviewers and Decision Rules
At least two independent reviewers evaluate each manuscript.
If one report is positive and the other is negative, the manuscript is sent to a third reviewer.
A single negative review is sufficient for rejection.
For acceptance, at least two upbeat or conditionally positive (minor/major Revision) reports are required.
If one reviewer requests “Major Revision” and another “Minor Revision” or “Accept,” the manuscript is returned to the reviewer requesting major Revision for a second assessment.
7. Requesting Additional Data
For manuscripts involving:
Clinical research
Biomedical datasets
Statistical analyses
Digital health records
Machine learning algorithms
Diagnostic images
Reviewers may request access to anonymized data through the editor. The editorial office will coordinate with the authors to ensure the ethical and confidential sharing of data.
8. Prohibited Conduct for Reviewers
Reviewers must not:
Use data, ideas, or findings from the manuscript for personal benefit
Contact authors directly
Delay the review intentionally
Demand citation of their own work unless scientifically justified
Share any review content with third parties
Reproduce or distribute manuscript content
9. Anonymity and Transparency
The journal strictly protects reviewer identities.
Reviewer names are never disclosed to authors or published publicly.